Helix BioPharma Corp. (HBP.TO)
0.82
-0.16
(-16.33%)
CAD |
TSX |
Oct 23, 16:00
Helix BioPharma Net Income (Quarterly) : -0.671M for April 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | -0.671M |
| January 31, 2026 | -0.694M |
| October 31, 2025 | -1.008M |
| July 31, 2025 | -0.95M |
| April 30, 2025 | -1.544M |
| January 31, 2025 | -1.375M |
| October 31, 2024 | -1.336M |
| July 31, 2024 | -5.278M |
| April 30, 2024 | -1.831M |
| January 31, 2024 | -0.902M |
| October 31, 2023 | -1.254M |
| July 31, 2023 | -2.154M |
| April 30, 2023 | -1.337M |
| January 31, 2023 | -1.185M |
| October 31, 2022 | -1.606M |
| July 31, 2022 | -1.386M |
| April 30, 2022 | -1.345M |
| January 31, 2022 | -2.019M |
| October 31, 2021 | -1.813M |
| July 31, 2021 | -2.77M |
| April 30, 2021 | -2.554M |
| January 31, 2021 | -1.866M |
| October 31, 2020 | -2.384M |
| July 31, 2020 | -1.966M |
| April 30, 2020 | -2.396M |
| Date | Value |
|---|---|
| January 31, 2020 | -2.255M |
| October 31, 2019 | -2.026M |
| July 31, 2019 | -2.037M |
| April 30, 2019 | -1.856M |
| January 31, 2019 | -1.908M |
| October 31, 2018 | -1.379M |
| July 31, 2018 | -1.61M |
| April 30, 2018 | -2.147M |
| January 31, 2018 | -2.564M |
| October 31, 2017 | -2.303M |
| July 31, 2017 | -1.24M |
| April 30, 2017 | -2.913M |
| January 31, 2017 | -2.618M |
| October 31, 2016 | -3.287M |
| July 31, 2016 | -2.604M |
| April 30, 2016 | -2.243M |
| January 31, 2016 | -2.226M |
| October 31, 2015 | -2.592M |
| July 31, 2015 | -2.119M |
| April 30, 2015 | -1.871M |
| January 31, 2015 | -2.665M |
| October 31, 2014 | -2.125M |
| July 31, 2014 | -1.804M |
| April 30, 2014 | -2.109M |
| January 31, 2014 | -2.632M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Microbix Biosystems, Inc. | -0.8068M |
| Sernova Biotherapeutics, Inc. | -2.529M |
| Hemostemix, Inc. | -0.6324M |
| Medicenna Therapeutics Corp. | -5.082M |
| Spectral Medical, Inc. | 0.331M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.671M |
| EPS Diluted (Quarterly) | -0.0088 |
| Enterprise Value | 60.15M |
| Earnings Yield | -5.37% |
| Normalized Earnings Yield | -5.366 |